This editorial highlights the health risks of monosodium glutamate, stressing the need for labeling regulations to protect consumers.
Monosodium Glutamate (MSG) is a widely used food additive that enhances flavors in processed foods. However, MSG is also linked to serious health risks, particularly for individuals susceptible to atrial fibrillation (AF) and its serious consequences.[i],[ii],Error! Reference source not found. There is an unmet need for uniform labeling regulations for MSG, as it is often listed under multiple names, creating confusion for consumers trying to avoid it. By exploring the current state of MSG labeling and its associated health risks, advocacy for clearer labeling practices to protect at-risk consumers is needed. Clear and uniform labeling of monosodium glutamate (MSG) is crucial for protecting vulnerable populations, particularly individuals sensitive to MSG-triggered atrial fibrillation. Current labeling practices inadequately inform consumers due to the additive’s many aliases, highlighting an urgent need for standardized regulatory action. This editorial might draw the focus of attention of the concerned authorities towards this important health issue. Abbreviations: AF: Atrial fibrillation, FDA: Food and Drug Administration, GRAS: generally regarded as safe, MSG: monosodium glutamate Keywords: Atrial fibrillation; GRAS; health risk; MSG; monosodium glutamate Citation: Purvez A, Valentine CM. The need for uniform labeling regulations for monosodium glutamate: addressing health risks and consumer protection. Anaesth. pain intensive care 2025;29(5):257-259. DOI: 10.35975/apic.v29i5.2860 Received: July 19, 2025; Accepted: July 22, 2025
No takes yet. Share an insight, caveat, or question.
Akhtar Purvez (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: